Perphenazine
SIGMA/P6402
Synonym: 4-[3-(2-Chloro-10H-
CAS Number: 58-39-9
Empirical Formula (Hill Notation): C21H26ClN3OS
Molecular Weight: 403.97
EC Number: 200-381-5
MDL Number: MFCD00056798
Linear Formula: C21H26ClN3OS
Product Type: Chemical
| form | powder |
| InChI | 1S/C21H26ClN3OS/c22-17-6- |
| InChI key | RGCVKNLCSQQDEP-UHFFFAOYSA |
| originator | Schering Plough |
| Quality Level | 200 ![]() |
| SMILES string | ClC(C=C1)=CC2=C1SC3=CC=CC |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | D2 dopamine receptor antagonist; α-adrenergic receptor antagonist and σ-receptor agonist; phenothiazine antipsychotic. Inhibits glutamate dehydrogenase in vitro. |
| Features and Benefits: | This compound was developed by Schering Plough . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Perphenazine is an antipsychotic drug used in treating schizophrenia. It modulates antioxidant levels and helps in the management of oxidative injury in schizophrenia. However, it is less effective than the clozapine drug group in improving response to oxidative injury. |
| Packaging: | 1, 5 g in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H317 |
| Precautionary statements | P261 - P264 - P270 - P280 - P301 + P312 - P302 + P352 |
| Hazard Codes | Xn |
| Risk Statements | 22-43 |
| Safety Statements | 28-36/37/39-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


